Jonathan A. kelber, Ph.D.
Affiliations: | Biology | California State University, Northridge, Los Angeles, CA, United States |
Area:
Cancer and Regenerative biology, receptor and non-receptor kinasesWebsite:
http://developmentaloncogenelab.gutensite.net/Google:
"Jonathan kelber"Mean distance: 16.18 (cluster 6) | S | N | B | C | P |
Parents
Sign in to add mentorWylie Vale | grad student | 2004-2009 | UCSD | |
(Mechanism, function and modulation of oncogenic Cripto signaling.) | ||||
Richard L. Klemke | post-doc | 2009-2012 | UCSD | |
Laurence L. Brunton | post-doc | 2010-2012 | UCSD | |
Joan S. Brugge | research scientist | 2017-2017 | Harvard Medical School (Biomechanics Tree) | |
Martin J. Humphries | research scientist | 2019-2020 | University of Manchester |
Children
Sign in to add traineeAnaline Aguayo | research assistant | CSUN (Chemistry Tree) | |
Megan Agajanian | grad student | 2013-2015 | CSUN |
Armen Gharibi | grad student | 2014-2016 | CSUN |
Yvess Adamian | grad student | 2014-2017 | CSUN |
Malachia Hoover | grad student | 2014-2017 | CSUN |
Justin Molnar | grad student | 2014-2017 | CSUN |
Preston Shisgal | grad student | 2014-2018 | CSUN |
Sarkis Hamalian | grad student | 2016-2018 | CSUN |
Kayla Meade | grad student | 2016-2018 | CSUN |
Sa La Kim | grad student | 2017-2019 | CSUN |
Cameron Geller | grad student | 2018-2020 | CSUN |
Francesca Sanchez | grad student | 2018-2020 | CSUN |
Matthew Wallace | grad student | 2019-2021 | CSUN |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Hamalian S, Güth R, Runa F, et al. (2021) A SNAI2-PEAK1-INHBA stromal axis drives progression and lapatinib resistance in HER2-positive breast cancer by supporting subpopulations of tumor cells positive for antiapoptotic and stress signaling markers. Oncogene |
Conner C, Lager TW, Guldner IH, et al. (2020) Cell surface GRP78 promotes stemness in normal and neoplastic cells. Scientific Reports. 10: 3474 |
Güth R, Adamian Y, Geller C, et al. (2019) DHPS-dependent hypusination of eIF5A1/2 is necessary for TGFβ/fibronectin-induced breast cancer metastasis and associates with prognostically unfavorable genomic alterations in TP53. Biochemical and Biophysical Research Communications |
Meade KJ, Sanchez F, Aguayo A, et al. (2019) Secretomes from metastatic breast cancer cells, enriched for a prognostically unfavorable LCN2 axis, induce anti-inflammatory MSC actions and a tumor-supportive premetastatic lung. Oncotarget. 10: 3027-3039 |
Sanchez F, Meade K, Aguayo A, et al. (2019) Abstract LB-129: Metastatic breast cancer cells promote anti-inflammatory MSC actions and release Lipocalin 2 to induce a tumor-supportive premetastatic lung microenvironment Cancer Research. 79 |
Hoover M, Runa F, Booker E, et al. (2018) Identification of myosin II as a cripto binding protein and regulator of cripto function in stem cells and tissue regeneration. Biochemical and Biophysical Research Communications |
Guth R, Kutscher L, Adamian Y, et al. (2018) Abstract 4998: Targeting DHPS to abrogate TGFβ-induced metastasis in breast cancer Cancer Research. 78: 4998-4998 |
Hamalian S, Güth R, Zervantonakis I, et al. (2018) Abstract 2140: Mesenchymal stromal cells expressing a PEAK1/Cripto axis sustain pro-survival NF-κB signaling in adjacent tumor cells to promote disease progression and therapy resistance Cancer Research. 78: 2140-2140 |
Lager TW, Conner HC, Guldner IH, et al. (2018) Abstract 1990: Aberrant cell surface expression of GRP78 in breast cancer cells marks a stem-like population that has increased metastatic potential in vivo Cancer Research. 78: 1990-1990 |
Runa F, Hamalian S, Meade K, et al. (2017) Tumor microenvironment heterogeneity: challenges and opportunities. Current Molecular Biology Reports. 3: 218-229 |